Table of Content

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulations

3. Market Determinants
3.1. Motivators
3.1.1. Increasing Prevalence of Type 2 Diabetes
3.1.2. Rising Demand for Non-Invasive Monitoring Devices
3.1.3. Increasing Government Initiatives
3.1.4. Rising Obesity Coupled with Change in Lifestyle
3.2. Restraints
3.2.1. High Cost of Diagnosis and Treatment
3.2.2. Stringent Regulatory Framework
3.3. Opportunities
3.3.1. Increasing Development of Pipeline Products

4. Market Segmentation
4.1. Global Type 2 Diabetes Market by Drug Class
4.1.1. Insulin
4.1.2. Non-Insulin (DPP-4 Inhibitor, GLP-1 Receptor, SGLT-2 Inhibitor)
4.2. Global Type 2 Diabetes Market by Devices
4.2.1. Insulin Pumps
4.2.2. Insulin Pen
4.2.3. Blood Glucose Meters
4.2.4. Others

5. Competitive Landscape
5.1. Strategy Analysis
5.2. Key Company Analysis

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. Japan
6.3.3. India
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company profiles
7.1. Abbott Laboratories, Inc.
7.2. AstraZeneca, PLC
7.3. Bayer AG
7.4. Becton, Dickinson and Co.
7.5. Boehringer Ingelheim International GmbH
7.6. Dexcom, Inc.
7.7. Eli Lilly and Co.
7.8. F. Hoffmann-La Roche Ltd.
7.9. GlaxoSmithKline, PLC
7.10. Johnson And Johnson Services, Inc.
7.11. LifeScan, Inc.
7.12. Medtronic, PLC
7.13. Merck & Co., Inc
7.14. Novo-Nordisk A/S
7.15. Pfizer, Inc.
7.16. Sanofi S.A.
7.17. Smiths Medical, Inc.
7.18. Takeda Pharmaceutical, Ltd.
7.19. Tandem Diabetes Care, Inc.
7.20. ViaCyte, Inc.



List of Figures


FIGURE # 1 GLOBAL TYPE 2 DIABETES MARKET SHARE BY DRUG CLASS, 2017 VS 2023, (IN %)
FIGURE # 2 GLOBAL TYPE 2 DIABETES MARKET SHARE BY DEVICES, 2017 VS 2023, (IN %)
FIGURE # 3 GLOBAL TYPE 2 DIABETES MARKET SHARE BY GEOGRAPHY, 2017 VS 2023, (IN %)
FIGURE # 4 NORTH AMERICAN TYPE 2 DIABETES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 5 US TYPE 2 DIABETES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 6 CANADA TYPE 2 DIABETES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 7 EUROPEAN TYPE 2 DIABETES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 8 UK TYPE 2 DIABETES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 9 FRANCE TYPE 2 DIABETES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 10 GERMANY TYPE 2 DIABETES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 11 ITALY TYPE 2 DIABETES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 12 SPAIN TYPE 2 DIABETES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 13 ROE TYPE 2 DIABETES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 14 ASIA PACIFIC TYPE 2 DIABETES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 15 INDIA TYPE 2 DIABETES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 16 CHINA TYPE 2 DIABETES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 17 JAPAN TYPE 2 DIABETES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 18 REST OF ASIA-PACIFIC TYPE 2 DIABETES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 19 REST OF THE WORLD TYPE 2 DIABETES MARKET SIZE, 2017-2023 ($ MILLION)

 

List of Tables


TABLE # 1 GLOBAL TYPE 2 DIABETES MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2017-2023 ($ MILLION)
TABLE # 2 GLOBAL INSULIN MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL NON-INSULIN MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL TYPE 2 DIABETES MARKET RESEARCH AND ANALYSIS BY DEVICES, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL INSULIN PUMPS MARKET RESEARCH AND ANALYSIS BY REGION, 2016-20223($ MILLIONS)
TABLE # 6 GLOBAL INSULIN PEN MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL BLOOD GLUCOSE MONITORS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL TYPE 2 DIABETES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
TABLE # 10 NORTH AMERICAN TYPE 2 DIABETES MARKET RESEARCH AND ANALYSIS DRUG CLASS, 2017-2023 ($ MILLION)
TABLE # 11 NORTH AMERICAN TYPE 2 DIABETES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 12 NORTH AMERICAN TYPE 2 DIABETES MARKET RESEARCH AND ANALYSIS BY DEVICES, 2017-2023 ($ MILLION)
TABLE # 13 EUROPEAN TYPE 2 DIABETES MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2017-2023 ($ MILLION)
TABLE # 14 EUROPEAN TYPE 2 DIABETES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 15 EUROPEAN TYPE 2 DIABETES MARKET RESEARCH AND ANALYSIS BY DEVICES, 2017-2023 ($ MILLION)
TABLE # 16 ASIA PACIFIC TYPE 2 DIABETES MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2017-2023 ($ MILLION)
TABLE # 17 ASIA PACIFIC TYPE 2 DIABETES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 18 ASIA PACIFIC TYPE 2 DIABETES MARKET RESEARCH AND ANALYSIS BY DEVICES, 2017-2023 ($ MILLION)
TABLE # 19 REST OF THE WORLD TYPE 2 DIABETES MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2017-2023 ($ MILLION)
TABLE # 20 REST OF THE WORLD TYPE 2 DIABETES MARKET RESEARCH AND ANALYSIS BY DEVICES, 2017-2023 ($ MILLION)